Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Other Accumulated Expenses (2016 - 2025)

Fortress Biotech (FBIO) has 9 years of Other Accumulated Expenses data on record, last reported at $135000.0 in Q3 2025.

  • For Q3 2025, Other Accumulated Expenses fell 86.99% year-over-year to $135000.0; the TTM value through Sep 2025 reached $135000.0, down 86.99%, while the annual FY2024 figure was $1.5 million, 822.7% up from the prior year.
  • Other Accumulated Expenses reached $135000.0 in Q3 2025 per FBIO's latest filing, down from $2.1 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $2.1 million in Q1 2025 and bottomed at $135000.0 in Q3 2025.
  • Average Other Accumulated Expenses over 4 years is $934833.3, with a median of $1.0 million recorded in 2022.
  • Peak YoY movement for Other Accumulated Expenses: plummeted 87.97% in 2024, then skyrocketed 1213.5% in 2025.
  • A 4-year view of Other Accumulated Expenses shows it stood at $996000.0 in 2022, then crashed by 83.63% to $163000.0 in 2023, then surged by 822.7% to $1.5 million in 2024, then crashed by 91.02% to $135000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $135000.0 in Q3 2025, $2.1 million in Q2 2025, and $2.1 million in Q1 2025.